Metraipolis › archive › dc_5fdd90fe8213

Comparative Efficacy and Safety of Once-Weekly Semaglutide Formulations in Indian Adults With Obesity: A Phase III, Randomized Non-inferiority… — Europe PMC PMID:41884323

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41884323
DOI
10.7759/cureus.105749
License (as archived)
solo-consultazione
Archived
2026-11-03T23:39:15.834Z
SHA-256 of the archived text
90040e98969b1fa61e9fe86508b73825c1e167f83331e64168f2c063962834f4
Stable URL of this page
https://metraipolis.com/documento/dc_5fdd90fe8213

How to cite

Comparative Efficacy and Safety of Once-Weekly Semaglutide Formulations in Indian Adults With Obesity: A Phase III, Randomized Non-inferiority… — Europe PMC PMID:41884323 — Europe PMC (en), https://europepmc.org/article/MED/41884323 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5fdd90fe8213 (Metraipolis archive dc_5fdd90fe8213, sha256 90040e98969b1fa61e9fe86508b73825c1e167f83331e64168f2c063962834f4)
BibTeX
@misc{dc5fdd90fe8213,
  title = {Comparative Efficacy and Safety of Once-Weekly Semaglutide Formulations in Indian Adults With Obesity: A Phase III, Randomized Non-inferiority… — Europe PMC PMID:41884323},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41884323},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5fdd90fe8213; sha256 90040e98969b1fa61e9fe86508b73825c1e167f83331e64168f2c063962834f4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41884323. Agents can read the archived copy with the MCP tool read_document.